A Study to Evaluate the Safety, Tolerability and Effectiveness of the Renew Insert in Treating Accidental Bowel Leakage
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Emily Lukacz, MD
University of California, San Diego, CA
Principal Investigator - Eric G Weiss, MD
Cleveland Clinic Florida
Principal Investigator - Mark Segall, MD
The medical office of Mark Segall MD
Principal Investigator - Steven D Wexner, MD
Cleveland Clinic Florida
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dr. Segall
Los Gatos, California, United States
- Ucsd Medical Center
San Diego, California, United States
- Cleveland Clinic Florida
Weston, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2009
- Primary completion
- 30 Nov 2011
- Completion
- 31 Dec 2011
- Last update posted
- 28 Nov 2013
- Registered enrollment
- 97
- Registry id
- NCT01475474
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.